GET THE APP

The potential molecular targets of Fangchinoline for cancer thera | 11014
Current Synthetic and Systems Biology

Current Synthetic and Systems Biology
Open Access

ISSN: 2332-0737

+44-20-4587-4809

The potential molecular targets of Fangchinoline for cancer therapy


4th World Conference on Synthetic Biology and Genetic Engineering

November 09-10, 2017 Singapore

Srishti Mishra

Yong Loo Lin School of Medicine, National University of Singapore, Singapore

Scientific Tracks Abstracts: Curr Synthetic Sys Biol

Abstract :

Background: Fangchinoline, a traditional Chinese medicine, is a bis-benzylisoquinoline alkaloid isolated from the dried root of Stephaniae tetrandrine S. Moore (family-Menispermaceae). It has been extensively used as an analgesic, anti-rheumatic and antihypertensive drug, possesses profound pharmacological activities and has gained a lot of interest due to its anti-cancer activity. Aim: This project aimed to investigate the potential anti-cancer effects of Fangchinoline in tumor cells and to identify the molecular targets underlying its mechanisms of action. Methods: The hepatocellular carcinoma cells and breast cancer cells were chosen to assess the effects of Fangchinoline on the cellular cytotoxicity, cell cycle progression, apoptosis and the migratory and invasive potential of these cells by MTT assay, flow cytometry, western blotting, wound healing assay and the invasion assay, respectively. Results: Fangchinoline showed significant cytotoxic effects on Huh-7 and MDA MB-231 cell lines. It arrested these cells at the sub-G1 phase of the cell cycle, induced significant apoptosis in both the tumor cells as evidenced by the activation of procaspase-3, the cleavage of PARP and downregulation of Bcl-2. Additionally, it also attenuated the migratory and invasive potential of both the cell lines significantly. The suppression of the phosphorylated AKT protein level was also observed upon the drug treatment. Conclusion: Overall, the preliminarily results shows that Fangchinoline exerts significant anti-cancer effects on the tumor cells predominantly via the inhibition of the AKT signaling cascade.

Biography :

Srishti Mishra has completed Genetic Engineering degree from SRM University, Chennai, India. She is a Research Assistant in the Department of Pharmacology at National University of Singapore and she has published 4 papers in reputed journals and has been engaged in mentoring the students in their research projects.
 

Top